But I liked understanding the nuts and bolts of how things work. So as an undergraduate at Duke University, I knew I wanted to study physics. The Human Genome Project had just come out, and I was ...

Researchers from The University of Western Australia, working with medtech industry partners Artrya, have developed a new, ...

An alternative diagnostic method could improve early detection and treatment of peripheral artery disease (PAD), according to ...

Affiliate Content: Here are the top circulation supplements for healthy blood flow in 2025, picked for their science-backed benefits and quality testing ...

Chart generates substantial free cash flow. Historical free cash flow conversion is well above 80% and Chart targets 90%-plus conversion after acquiring Howden.

Coronary artery disease remains a significant global health concern, leading to high morbidity and mortality, with conditions like spontaneous coronary artery dissection (SCAD) presenting unique ...

Flowserve Corporation and Chart Industries, Inc. merge for $300M synergies, sparking investor skepticism on growth and strategy. Click for my take on FLS and GTLS.

Chart Industries and Flowserve agreed to combine in an all-stock merger valued at ~$19B including debt, creating a differentiated leader in industrial process technologies.

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion.

By Colin Kellaher Shares of Chart Industries and Flowserve moved lower in premarket trading Wednesday after the companies agreed to combine in an all-stock merger.

(Reuters) -U.S.-based equipment manufacturer Chart Industries and flow control systems maker Flowserve Corp agreed to merge in an all-stock deal, valuing the combined company at about $19 billion.

5 Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global Coronary Flow Reserve is Associated with Adverse Cardiovascular Events Independently of Luminal Angiographic ...